本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ligand Pharmaceuticals Inc.

201.66
+1.300.65%
盤後201.660.00000.00%16:05 EDT
成交量:21.46萬
成交額:4,295.46萬
市值:40.21億
市盈率:32.90
高:202.07
開:200.88
低:195.45
收:200.36
52周最高:227.92
52周最低:93.58
股本:1,994.11萬
流通股本:1,945.76萬
量比:0.80
換手率:1.10%
股息:- -
股息率:- -
每股收益(TTM):6.13
每股收益(LYR):6.13
淨資產收益率:13.47%
總資產收益率:2.36%
市淨率:3.95
市盈率(LYR):32.90

資料載入中...

2026/03/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities